Keyphrases
Intensive Care
53%
Maastricht
53%
Coronavirus Disease (COVID)
53%
Sarcoidosis
32%
Rotational Thromboelastometry (ROTEM)
32%
Polymorphism
15%
Low Molecular Weight Heparin
14%
COVID-19
13%
Drug-induced
12%
Risk Factors
12%
Critically Ill COVID-19 Patients
12%
Fibrinogen
12%
Unfractionated Heparin
12%
Dutch
11%
Nephrolithiasis
10%
Risk Stratification
10%
Drug-induced Interstitial Lung Disease
10%
COVID-19 Disease
10%
Critical COVID-19
10%
Heparin Monitoring
10%
Drug-gene
10%
Patient Observation
10%
Comorbidity
10%
Dephosphorylated Uncarboxylated Matrix Gla Protein
10%
Matrix Gla Protein
10%
Vitamin K Epoxide Reductase
10%
Thrombin Generation
10%
Alternative Anticoagulants
10%
Quantra
10%
QPlus
10%
Goal-directed Transfusions
10%
Surgery Patients
10%
Clinical Pattern
10%
Prospective Observational Study
10%
Cardiothoracic Surgery
10%
Transfusion Protocol
10%
Uveitis
10%
National Collaboration
10%
COVID-19 Pandemic
10%
Vitamin K Antagonists
10%
Patients at Risk
10%
Plasma Proteomics
10%
Proteomic Profile
10%
Non-survivors
9%
Drug Use
8%
Transfusion
8%
Plasma Profile
7%
Mass Spectrometry
7%
Plasma Protein Levels
7%
SARS-CoV-2 Infection
7%
International Normalized Ratio
7%
Intensive Care Unit
7%
Tissue Plasminogen Activator (t-PA)
6%
Clotting Time
6%
Intubation
6%
Survivors
6%
Hemostasis
6%
University Medical Centre
6%
Maastricht University
6%
Activated Partial Thromboplastin Time (aPTT)
6%
CT Ratio
6%
Pulmonary Embolism
5%
Intensive Care Unit Mortality
5%
Adverse Drug Reaction
5%
EXTEM
5%
FIBTEM
5%
International Collaboration
5%
Novel Disease
5%
Venous Thromboembolism
5%
INIS
patients
100%
diseases
39%
risks
39%
covid-19
32%
comparative evaluations
25%
proteins
24%
vitamin k
22%
units
21%
drugs
21%
exploration
21%
levels
19%
mortality
18%
heparin
15%
monitoring
14%
plasma
14%
genetics
14%
genes
13%
data
13%
biological markers
12%
design
11%
anticoagulants
11%
fibrinogen
11%
stratification
10%
matrices
10%
interstitials
10%
applications
10%
lungs
10%
reductases
10%
thrombin
10%
epoxides
10%
surgery
10%
transfusions
10%
appraisal
10%
tissues
10%
inflammation
9%
plasminogen
8%
molecular weight
7%
adjustments
6%
organs
5%
lysis
5%
coronaviruses
5%
trajectories
5%
evaluation
5%
Medicine and Dentistry
Intensive Care
53%
COVID-19
53%
Thromboelastometry
32%
Sarcoidosis
21%
Intensive Care Unit
19%
Diseases
15%
Observational Study
12%
Heparin
12%
Anticoagulant
10%
Risk Stratification
10%
Kidney Stone
10%
Retinol
10%
Thrombin
10%
Biological Marker
10%
Interstitial Lung Disease
10%
Vitamin K Epoxide Reductase
10%
Thorax Surgery
10%
Matrix Gla Protein
10%
Comorbidity
10%
Critical Appraisal
10%
Low Molecular Weight Heparin
10%
Fibrinogen
8%
Intubation
6%
Tissue Plasminogen Activator
6%
Blood Stasis
6%
Pulmonary Embolism
5%